Medications for Myelodysplastic Syndrome

4 results

  • inqovi - cedazuridine and decitabine tablet, film coated

    (Cedazuridine And Decitabine)
    Taiho Pharmaceutical Co., Ltd.
    INQOVI treats adult patients with myelodysplastic syndromes (MDS) — including refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and CMML — across intermediate-1, intermediate-2, and high-risk IPSS groups, both previously treated and untreated.
    Medication Details
    Drug Interactions

  • reblozyl - luspatercept injection, powder, lyophilized, for solution

    (Luspatercept)
    Celgene Corporation
    Reblozyl treats anemia in adults with beta thalassemia requiring regular RBC transfusions, ESA-naïve adults with very low- to intermediate-risk MDS requiring transfusions, and adults with MDS-RS or MDS/MPN-RS-T failing ESA and requiring 2+ RBC units over 8 weeks.
    Medication Details

  • rytelo - imetelstat sodium injection, powder, lyophilized, for solution

    (Imetelstat Sodium)
    Geron Corporation
    Rytelo treats adults with low- to intermediate-1 risk myelodysplastic syndromes (MDS) and transfusion-dependent anemia (4+ red blood cell units per 8 weeks) who have not responded to, lost response to, or are ineligible for erythropoiesis-stimulating agents.
    Medication Details
    Drug Interactions

  • tibsovo - ivosidenib tablet, film coated

    (Ivosidenib)
    Servier Pharmaceutical Llc
    Tibsovo is an IDH1 inhibitor for adults with susceptible IDH1 mutations. Indicated for newly diagnosed AML in patients 75+ or unfit for intensive chemotherapy, relapsed or refractory AML, relapsed or refractory myelodysplastic syndromes, and previously treated locally advanced or metastatic cholangiocarcinoma.
    Medication Details
    Drug Interactions